12.11.2024 11:46:38 CET | Aqua Bio Technology ASA | Total number of voting rights and capital
Reference is made to the stock exchange announcement from Aqua Bio Technology ASA (“ABT” or the “Company”) on 29 August 2024, regarding the Company’s board of directors’ resolution to issue a total of 5,000,000 new shares (the “New Shares”) in connection with the settlement of the share component of the purchase price for ABT’s acquisition of 3D Innovation Nordic AS.
The share capital increase pertaining to the issuance of the New Shares has today been registered with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret). ABT’s new share capital is NOK 173,723,182.50 divided into 69,489,273 shares, each with a nominal value of NOK 2.50. The New Shares will be delivered on a separate ISIN pending publication of an EEA listing prospectus approved by the Norwegian Financial Supervisory Authority.
For further information, please contact Jan Varming, CFO, telephone +47 90 83 90 76.
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Disclosure regulation
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
Contacts
Jan Aas Varming, CFO, Aqua Bio Technology ASA, +47 908 39 076, jan@aquabiotech.no
About Aqua Bio Technology ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainablebiotechnology for use in skin care products. ABT’s cosmetics ingredients arehighly effective and they provide the cosmetics industry with naturalalternatives to traditional ingredients. ABT is also marketing and distributingnatural skin care products developed by partners towards consumers andprofessional users. Aqua Bio Technology is listed on Euronext Expand.
Attachments
Download announcement as PDF.pdf
